qtrn(quintiles trans) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : qtrn(quintiles trans)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (45)	9/27/1999 8:28:00 PM
From: Marty	Read Replies (1) of 105

I figured that since QTRN plunked down so much $ for ENVY that they must have somehow satisfied themselves on this issue. I can't conceive of so much money passing without this question being resolved to QTRN's complete satisfaction. After all, if your data is used within a billion others for medical research purposes, what damages have you sustained? I agree with QTRN that there is a tremendous potential value to the database. There is research value to find out what works better than what and so on and there is marketing value as to who is using what procedure and prescribing what drugs for what diagnosis. Those in the CRO business see other questions that could be answered and have a good payoff. It is like someone finding a big value in trash and going out and buying trash collection companies to get the trash. The trash collection companies used to think their value was in their customer contracts and trucks and employees and know how and so on but their real value, in the eyes of the buyer, as it turns out is in the trash they used to just dump.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next